Cancer
Book information
Description
The last decade has seen a dramatic shift in anticancer drug research towards agents that aim to selectively target key regulatory and signaling processes known to drive tumorigenesis. A number of these newer agents have now been introduced into clinical practice. This volume reviews advances in cancer chemotherapy research over the last 10 years and will be of interest to scientists engaged in drug research in the pharmaceutical industry, biotechnology and startup companies, academia and government institutions. Chapters written by leading experts in their field reflect a range of current medicinal chemistry approaches to small molecule drugs, including anti-hormonal therapy, growth factor inhibition, survival signaling, cell cycle inhibition, anti-angiogenics and anti-nvasives. Each chapter aims to cover the drug target and biological rationale, chemotypes, clinical status and future prospects in this rapidly developing area of drug research.
Similar books
Cancer
2007 · PDF
Transporters as Targets for Drugs
2009 · PDF
Ion Channels
2008 · PDF
Alzheimer's Disease
2008 · PDF
The Steric Factor in Medicinal Chemistry: Dissymmetric Probes of Pharmacological Receptors
1993 · PDF
Cancer
2007 · PDF
Ion Channels
2008 · PDF
Alzheimer's Disease
2008 · PDF